{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:35:39Z","timestamp":1794674139708,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003065","name":"University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sports Med - Open"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent evidence suggests that moderately elevated bilirubin plasma concentrations possess protective effects against non-communicable diseases. One possible explanation for this might be that Gilbert\u2019s Syndrome (GS), a mildly hyperbilirubinaemic condition, leads to an enhanced lipid metabolism. Furthermore, there are first hints that individuals with GS may have a greater performance capacity. We hypothesize that GS participants have a greater maximal fat oxidation and performance capacity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To test this, we conducted an age- and gender-matched human case-control study. We included 40 people with GS and 40 controls, aged 18\u201365 years, who were all moderately physically active. 50% of the participants were over the age of 35. Participants performed a FatMax test on a bicycle ergometer. The study was performed from March 2023 to December 2023 at the University of Vienna.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The group of GS participants over the age of 35 had a significantly higher FatMax (GS: median\u2009=\u20091.03 [maximum\u2009=\u20090.44; minimum\u2009=\u20092.42] W\/kg body weight; C: median\u2009=\u20090.48 [minimum\u2009=\u20090.33; maximum\u2009=\u20091.61] W\/kg body weight,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) and a significantly greater oxygen consumption (GS: mean\u2009=\u200930.2\u2009\u00b1\u2009standard diviation (sd)\u2009=\u20098.09\u00a0ml\/min\/ kg body weight; C: mean\u2009=\u200923.4\u2009\u00b1\u2009sd\u2009=\u20095.91\u00a0ml\/min\/kg body weight,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) at the respiratory compensation point.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first study to demonstrate that older GS individuals can generate more power whilst harnessing fatty acid metabolism and this may enhance their performance over prolonged periods of sub-maximal exercise.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40798-026-01011-2","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:09:30Z","timestamp":1776247770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Flexibility and Exercise Performance in Adults with Gilbert\u2019s Syndrome\u2013Associated Hyperbilirubinemia"],"prefix":"10.1186","volume":"12","author":[{"given":"Tamara Christina","family":"Stelzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Kripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Draxler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Maqboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Tatjana","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Cameron","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"1","key":"1011_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40842-023-00159-0","volume":"10","author":"M Nikouei","year":"2024","unstructured":"Nikouei M, Cheraghi M, Ghaempanah F, Kohneposhi P, Saniee N, Hemmatpour S, et al. The association between bilirubin levels, and the incidence of metabolic syndrome and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Clin Diabetes Endocrinol. 2024;10(1):1.","journal-title":"Clin Diabetes Endocrinol"},{"key":"1011_CR2","doi-asserted-by":"crossref","unstructured":"Seyed Khoei N, Anton G, Peters A, Freisling H, Wagner KH. The Association between Serum Bilirubin Levels and Colorectal Cancer Risk: Results from the Prospective Cooperative Health Research in the Region of Augsburg (KORA) Study in Germany. Antioxid (Basel). 2020;9(10).","DOI":"10.3390\/antiox9100908"},{"issue":"10","key":"1011_CR3","doi-asserted-by":"publisher","first-page":"e113835","DOI":"10.1016\/j.amjmed.2015.04.019","volume":"128","author":"SS Huang","year":"2015","unstructured":"Huang SS, Chan WL, Leu HB, Huang PH, Lin SJ, Chen JW. Serum bilirubin levels predict future development of metabolic syndrome in healthy middle-aged nonsmoking men. Am J Med. 2015;128(10):e113835\u201341.","journal-title":"Am J Med"},{"issue":"1","key":"1011_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20140566","volume":"129","author":"KH Wagner","year":"2015","unstructured":"Wagner KH, Wallner M, M\u00f6lzer C, Gazzin S, Bulmer AC, Tiribelli C, et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci (Lond). 2015;129(1):1\u201325.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"1011_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/10408363.2018.1428526","volume":"55","author":"KH Wagner","year":"2018","unstructured":"Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert\u2019s syndrome. Crit Rev Clin Lab Sci. 2018;55(2):129\u201339.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"9001","key":"1011_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","volume":"347","author":"G Monaghan","year":"1996","unstructured":"Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert\u2019s syndrome. Lancet. 1996;347(9001):578\u201381.","journal-title":"Lancet"},{"issue":"1","key":"1011_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00431-011-1641-0","volume":"171","author":"A Fretzayas","year":"2012","unstructured":"Fretzayas A, Moustaki M, Liapi O, Karpathios T. Gilbert syndrome. Eur J Pediatr. 2012;171(1):11\u20135.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1011_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","volume":"28","author":"J Fevery","year":"2008","unstructured":"Fevery J. Bilirubin in clinical practice: a review. Liver Int. 2008;28(5):592\u2013605.","journal-title":"Liver Int"},{"issue":"1","key":"1011_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/03602530903209429","volume":"42","author":"CP Strassburg","year":"2010","unstructured":"Strassburg CP. Gilbert-Meulengracht\u2019s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Drug Metab Rev. 2010;42(1):168\u201381.","journal-title":"Drug Metab Rev"},{"issue":"2","key":"1011_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.aohep.2019.02.001","volume":"18","author":"L Vitek","year":"2019","unstructured":"Vitek L, Hubacek JA, Pajak A, Dory\u0144ska A, Kozela M, Eremiasova L, et al. Association between plasma bilirubin and mortality. Ann Hepatol. 2019;18(2):379\u201385.","journal-title":"Ann Hepatol"},{"issue":"5","key":"1011_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/15353702-0322805-29","volume":"228","author":"L Novotn\u00fd","year":"2003","unstructured":"Novotn\u00fd L, V\u00edtek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228(5):568\u201371.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"1011_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.01.001","volume":"198","author":"HA Schwertner","year":"2008","unstructured":"Schwertner HA, V\u00edtek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198(1):1\u201311.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1011_CR13","doi-asserted-by":"publisher","first-page":"H429","DOI":"10.1152\/ajpheart.00417.2017","volume":"315","author":"AC Bulmer","year":"2018","unstructured":"Bulmer AC, Bakrania B, Du Toit EF, Boon AC, Clark PJ, Powell LW, et al. Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea. Am J Physiol Heart Circ Physiol. 2018;315(3):H429\u201347.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"1011_CR14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2337\/db14-0228","volume":"64","author":"A Abbasi","year":"2015","unstructured":"Abbasi A, Deetman PE, Corpeleijn E, Gansevoort RT, Gans RO, Hillege HL, et al. Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes. 2015;64(4):1459\u201369.","journal-title":"Diabetes"},{"issue":"2","key":"1011_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2008.07.021","volume":"203","author":"LY Lin","year":"2009","unstructured":"Lin LY, Kuo HK, Hwang JJ, Lai LP, Chiang FT, Tseng CD, et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis. 2009;203(2):563\u20138.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1011_CR16","first-page":"10","volume":"155","author":"L V\u00edtek","year":"2016","unstructured":"V\u00edtek L. [Role of bilirubin in the prevention of cardiovascular diseases and cancer]. Cas Lek Cesk. 2016;155(2):10\u20134.","journal-title":"Cas Lek Cesk"},{"key":"1011_CR17","doi-asserted-by":"publisher","first-page":"30051","DOI":"10.1038\/srep30051","volume":"6","author":"C M\u00f6lzer","year":"2016","unstructured":"M\u00f6lzer C, Wallner M, Kern C, Tosevska A, Schwarz U, Zadnikar R, et al. Features of an altered AMPK metabolic pathway in Gilbert\u2019s Syndrome, and its role in metabolic health. Sci Rep. 2016;6:30051.","journal-title":"Sci Rep"},{"key":"1011_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2017.12.021","volume":"269","author":"N Seyed Khoei","year":"2018","unstructured":"Seyed Khoei N, Grindel A, Wallner M, M\u00f6lzer C, Doberer D, Marculescu R, et al. Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health. Atherosclerosis. 2018;269:306\u201311.","journal-title":"Atherosclerosis"},{"key":"1011_CR19","doi-asserted-by":"crossref","unstructured":"Wagner KH, Khoei NS, Hana CA, Doberer D, Marculescu R, Bulmer AC et al. Oxidative Stress and Related Biomarkers in Gilbert\u2019s Syndrome: A Secondary Analysis of Two Case-Control Studies. Antioxid (Basel). 2021;10(9).","DOI":"10.3390\/antiox10091474"},{"key":"1011_CR20","doi-asserted-by":"publisher","first-page":"701109","DOI":"10.3389\/fcimb.2021.701109","volume":"11","author":"PA Z\u00f6hrer","year":"2021","unstructured":"Z\u00f6hrer PA, Hana CA, Seyed Khoei N, M\u00f6lzer C, H\u00f6rmann-Wallner M, Tosevska A, et al. Gilbert\u2019s Syndrome and the Gut Microbiota - Insights From the Case-Control BILIHEALTH Study. Front Cell Infect Microbiol. 2021;11:701109.","journal-title":"Front Cell Infect Microbiol"},{"key":"1011_CR21","doi-asserted-by":"publisher","first-page":"154913","DOI":"10.1016\/j.metabol.2021.154913","volume":"125","author":"CA Hana","year":"2021","unstructured":"Hana CA, Tran LV, M\u00f6lzer C, M\u00fcllner E, H\u00f6rmann-Wallner M, Franzke B, et al. Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert\u2019s syndrome individuals. Metabolism. 2021;125:154913.","journal-title":"Metabolism"},{"issue":"5","key":"1011_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20120661","volume":"125","author":"M Wallner","year":"2013","unstructured":"Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert\u2019s syndrome. Clin Sci (Lond). 2013;125(5):257\u201364.","journal-title":"Clin Sci (Lond)"},{"issue":"16\u201317","key":"1011_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.clinbiochem.2014.08.008","volume":"47","author":"RP Dullaart","year":"2014","unstructured":"Dullaart RP, de Vries R, Lefrandt JD. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus. Clin Biochem. 2014;47(16\u201317):170\u20135.","journal-title":"Clin Biochem"},{"key":"1011_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1758-5996-7-4","volume":"7","author":"H Nascimento","year":"2015","unstructured":"Nascimento H, Alves AI, Coimbra S, Catarino C, Gomes D, Bronze-da-Rocha E, et al. Bilirubin is independently associated with oxidized LDL levels in young obese patients. Diabetol Metab Syndr. 2015;7:4.","journal-title":"Diabetol Metab Syndr"},{"key":"1011_CR25","doi-asserted-by":"crossref","unstructured":"Hinds TD Jr., Creeden JF, Gordon DM, Spegele AC, Britton SL, Koch LG et al. Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1. Antioxid (Basel). 2020;9(9).","DOI":"10.3390\/antiox9090889"},{"issue":"1","key":"1011_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40798-022-00463-6","volume":"8","author":"J Woronyczov\u00e1","year":"2022","unstructured":"Woronyczov\u00e1 J, Nov\u00e1kov\u00e1 M, Len\u00ed\u010dek M, B\u00e1tovsk\u00fd M, Bolek E, C\u00edfkov\u00e1 R, et al. Serum Bilirubin Concentrations and the Prevalence of Gilbert Syndrome in Elite Athletes. Sports Med Open. 2022;8(1):84.","journal-title":"Sports Med Open"},{"key":"1011_CR27","doi-asserted-by":"crossref","unstructured":"Thomas DT, DelCimmuto NR, Flack KD, Stec DE, Hinds TD. Jr. Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin. Antioxid (Basel). 2022;11(2).","DOI":"10.3390\/antiox11020179"},{"key":"1011_CR28","doi-asserted-by":"publisher","first-page":"1040687","DOI":"10.3389\/fspor.2022.1040687","volume":"4","author":"KD Flack","year":"2022","unstructured":"Flack KD, V\u00edtek L, Fry CS, Stec DE, Hinds TD. Jr. Cutting edge concepts: Does bilirubin enhance exercise performance? Front Sports Act Living. 2022;4:1040687.","journal-title":"Front Sports Act Living"},{"issue":"4","key":"1011_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1249\/MSS.0b013e3182357dd4","volume":"44","author":"DL Swift","year":"2012","unstructured":"Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS. Effect of different doses of aerobic exercise training on total bilirubin levels. Med Sci Sports Exerc. 2012;44(4):569\u201374.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"1011_CR30","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jhep.2021.06.010","volume":"75","author":"L V\u00edtek","year":"2021","unstructured":"V\u00edtek L, Tiribelli C, Bilirubin. The yellow hormone? J Hepatol. 2021;75(6):1485\u201390.","journal-title":"J Hepatol"},{"issue":"7","key":"1011_CR31","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s40279-025-02213-6","volume":"55","author":"A Naderi","year":"2025","unstructured":"Naderi A, Rothschild JA, Santos HO, Hamidvand A, Koozehchian MS, Ghazzagh A, et al. Nutritional Strategies to Improve Post-exercise Recovery and Subsequent Exercise Performance: A Narrative Review. Sports Med. 2025;55(7):1559\u201377.","journal-title":"Sports Med"},{"issue":"12","key":"1011_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"1011_CR33","doi-asserted-by":"publisher","first-page":"166097","DOI":"10.1016\/j.bbadis.2021.166097","volume":"1867","author":"A Berthier","year":"2021","unstructured":"Berthier A, Johanns M, Zummo FP, Lefebvre P, Staels B. PPARs in liver physiology. Biochim Biophys Acta Mol Basis Dis. 2021;1867(5):166097.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1011_CR34","doi-asserted-by":"crossref","unstructured":"Grabacka M, Pierzchalska M, Dean M, Reiss K. Regulation of Ketone Body Metabolism and the Role of PPAR\u03b1. Int J Mol Sci. 2016;17(12).","DOI":"10.3390\/ijms17122093"},{"issue":"4","key":"1011_CR35","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jhep.2023.06.004","volume":"79","author":"L V\u00edtek","year":"2023","unstructured":"V\u00edtek L, Tiribelli C. Gilbert\u2019s syndrome revisited. J Hepatol. 2023;79(4):1049\u201355.","journal-title":"J Hepatol"},{"issue":"8","key":"1011_CR36","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00421-020-04397-3","volume":"120","author":"OJ Chrzanowski-Smith","year":"2020","unstructured":"Chrzanowski-Smith OJ, Edinburgh RM, Thomas MP, Haralabidis N, Williams S, Betts JA, et al. The day-to-day reliability of peak fat oxidation and FAT(MAX). Eur J Appl Physiol. 2020;120(8):1745\u201359.","journal-title":"Eur J Appl Physiol"},{"issue":"8","key":"1011_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"Suppl 1","key":"1011_CR38","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1055\/s-2004-830512","volume":"26","author":"AE Jeukendrup","year":"2005","unstructured":"Jeukendrup AE, Wallis GA. Measurement of substrate oxidation during exercise by means of gas exchange measurements. Int J Sports Med. 2005;26(Suppl 1):S28\u201337.","journal-title":"Int J Sports Med"},{"key":"1011_CR39","doi-asserted-by":"crossref","unstructured":"Nunes R, Silva J, Machado A, Menezes L, Bocalini D, Seixas I et al. Prediction of vo2 max in healthy non-athlete men based on ventilatory threshold (Predicci\u00f3n de vo2 max en hombres sanos no atletas basado en umbral de ventilatorio). Retos. 2018.","DOI":"10.47197\/retos.v0i35.62165"},{"issue":"4","key":"1011_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1089\/bio.2015.0064","volume":"14","author":"G Lucena-Aguilar","year":"2016","unstructured":"Lucena-Aguilar G, S\u00e1nchez-L\u00f3pez AM, Barber\u00e1n-Aceituno C, Carrillo-\u00c1vila JA, L\u00f3pez-Guerrero JA, Aguilar-Quesada R. DNA Source Selection for Downstream Applications Based on DNA Quality Indicators Analysis. Biopreserv Biobank. 2016;14(4):264\u201370.","journal-title":"Biopreserv Biobank"},{"key":"1011_CR41","unstructured":"Stewart A, Marfell-Jones M, De Olds T. Ridder J. International Standards for Anthropometric Assessment2011."},{"issue":"7","key":"1011_CR42","doi-asserted-by":"publisher","first-page":"110234","DOI":"10.1016\/j.isci.2024.110234","volume":"27","author":"V Schoissengeier","year":"2024","unstructured":"Schoissengeier V, Maqboul L, Weber D, Grune T, B\u00fcrkle A, Moreno-Villaneuva M, et al. Association between bilirubin and biomarkers of metabolic health and oxidative stress in the MARK-AGE cohort. iScience. 2024;27(7):110234.","journal-title":"iScience"},{"issue":"10","key":"1011_CR43","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1158\/1940-6207.CAPR-13-0125","volume":"6","author":"M Wallner","year":"2013","unstructured":"Wallner M, Antl N, Rittmannsberger B, Schreidl S, Najafi K, M\u00fcllner E, et al. Anti-genotoxic potential of bilirubin in vivo: damage to DNA in hyperbilirubinemic human and animal models. Cancer Prev Res (Phila). 2013;6(10):1056\u201363.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"1011_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","year":"1998","unstructured":"Development of the World Health Organization WHOQOL-BREF quality of life assessment. WHOQOL Group Psychol Med. 1998;28(3):551\u20138.","journal-title":"WHOQOL Group Psychol Med"},{"issue":"2","key":"1011_CR45","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","volume":"320","author":"JF Creeden","year":"2021","unstructured":"Creeden JF, Gordon DM, Stec DE, Hinds TD. Jr. Bilirubin as a metabolic hormone: the physiological relevance of low levels. Am J Physiol Endocrinol Metab. 2021;320(2):E191\u2013207.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1011_CR46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1042\/CS20242825","volume":"139","author":"WH Lee","year":"2025","unstructured":"Lee WH, Kipp ZA, Pauss SN, Martinez GJ, Bates EA, Badmus OO, et al. Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics. Clin Sci (Lond). 2025;139(2):171\u201398.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"1011_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1194\/jlr.M011320","volume":"52","author":"T Goto","year":"2011","unstructured":"Goto T, Lee JY, Teraminami A, Kim YI, Hirai S, Uemura T, et al. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res. 2011;52(5):873\u201384.","journal-title":"J Lipid Res"},{"key":"1011_CR48","doi-asserted-by":"crossref","unstructured":"Kong F, Zhu M, Pan X, Zhao L, Yang S, Zhuo J et al. The Metabolome Characteristics of Aerobic Endurance Development in Adolescent Male Rowers Using Polarized and Threshold Model: An Original Research. Metabolites. 2025;15(1).","DOI":"10.3390\/metabo15010017"},{"issue":"2","key":"1011_CR49","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","volume":"199","author":"AC Bulmer","year":"2008","unstructured":"Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert\u2019s syndrome: a mechanism for cardiovascular protection. Atherosclerosis. 2008;199(2):390\u20136.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1011_CR50","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.112.105775","volume":"126","author":"T Maruhashi","year":"2012","unstructured":"Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation. 2012;126(5):598\u2013603.","journal-title":"Circulation"},{"issue":"11","key":"1011_CR51","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1515\/cclm.2011.662","volume":"49","author":"HJ Hwang","year":"2011","unstructured":"Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med. 2011;49(11):1823\u20138.","journal-title":"Clin Chem Lab Med"},{"key":"1011_CR52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1475-2840-12-166","volume":"12","author":"PE Deetman","year":"2013","unstructured":"Deetman PE, Bakker SJ, Dullaart RP. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc Diabetol. 2013;12:166.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1011_CR53","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/JS9.0000000000002260","volume":"111","author":"J Li","year":"2025","unstructured":"Li J, Pandian V, Davidson PM, Song Y, Chen N, Fong DYT. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Int J Surg. 2025;111(3):2385\u201397.","journal-title":"Int J Surg"},{"issue":"1","key":"1011_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcsm.13642","volume":"16","author":"J Wu","year":"2025","unstructured":"Wu J, Xu JH, Zou HQ, Ouyang YJ, Li SJ, Wu L, et al. Assessing Association Between Circulating Bilirubin Levels and the Risk of Frailty: An Observational and Mendelian Randomization Study. J Cachexia Sarcopenia Muscle. 2025;16(1):1\u201311.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1011_CR55","doi-asserted-by":"publisher","first-page":"1567050","DOI":"10.3389\/fmed.2025.1567050","volume":"12","author":"C Ling","year":"2025","unstructured":"Ling C, Tian L, Zhang C, Tian Y. Relationship between serum total bilirubin and frailty in middle-aged and elderly individuals. Front Med (Lausanne). 2025;12:1567050.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"1011_CR56","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.freeradbiomed.2012.03.002","volume":"52","author":"AC Boon","year":"2012","unstructured":"Boon AC, Hawkins CL, Bisht K, Coombes JS, Bakrania B, Wagner KH, et al. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Radic Biol Med. 2012;52(10):2120\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1011_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/ATVBAHA.122.318086","volume":"43","author":"Q Su","year":"2023","unstructured":"Su Q, Chen H, Du S, Dai Y, Chen C, He \u4f55\u5929\u654f T, et al. Association Between Serum Bilirubin, Lipid Levels, and Prevalence of Femoral and Carotid Atherosclerosis: A Population-Based Cross-Sectional Study. Arterioscler Thromb Vasc Biol. 2023;43(1):136\u201345.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1011_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2012.11.001","volume":"52","author":"AC Bulmer","year":"2013","unstructured":"Bulmer AC, Verkade HJ, Wagner KH. Bilirubin and beyond: a review of lipid status in Gilbert\u2019s syndrome and its relevance to cardiovascular disease protection. Prog Lipid Res. 2013;52(2):193\u2013205.","journal-title":"Prog Lipid Res"}],"container-title":["Sports Medicine - Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40798-026-01011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40798-026-01011-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40798-026-01011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:01:51Z","timestamp":1776250911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40798-026-01011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1186\/s40798-026-01011-2","relation":{},"ISSN":["2198-9761"],"issn-type":[{"value":"2198-9761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with the approval of the Ethics commission of the University of Vienna (#00905). Participants all gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All participants gave their consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"43"}}